Evidence map›Paper›PMID 39148405›Full record

ArticleDrug testing and analysis2025

Beta

Morten Hostrup, Glenn A Jacobson, Kasper Eibye, Christian K Narkowicz, David S Nichols, Søren Jessen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug testing and analysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. BetaDrug testing and analysis · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Morten HostrupAugust Krogh Section for Human Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-6201-2483
Glenn A JacobsonSchool of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, Australia.ORCID https://orcid.org/0000-0002-3409-8769
Kasper EibyeAugust Krogh Section for Human Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
Christian K NarkowiczSchool of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, Australia.
David S NicholsCentral Science Laboratory, University of Tasmania, Hobart, Australia.
Søren JessenAugust Krogh Section for Human Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-7461-1264

Funding

Anti Doping DanmarkDanish Ministry of Culture (Sports Science)
6 · The paper itself

Abstract

Salbutamol is a common short-acting beta

Indexed as

Adrenergic beta-2 Receptor AgonistsAlbuterolMuscle, SkeletalAdministration, OralAdultChromatography, High Pressure LiquidHumansMaleStereoisomerismTandem Mass SpectrometryYoung AdultAdrenergic beta-2 Receptor AgonistsAlbuterolalbuterolbeta‐2levalbuterolpharmacokineticsSABA

Identifiers

PMID39148405
PMCPMC12151713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.